PET scan for rising PSA after prostate cancer treatment
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This Phase 3 trial tests whether a special PET scan using 68Ga-PSMA-11 can detect prostate cancer that has returned after surgery or radiation, measured by rising PSA. If the scan works well, it may help doctors find where the cancer is coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign written consent.
- You are a Chinese man aged 18 or older.
- You previously had prostate cancer confirmed on biopsy, and you’ve had surgery and/or radiation, and your PSA has started rising again within the last 30 days.
- After surgery: your PSA is at least 0.2 ng/mL measured at least 6 weeks after surgery; OR after radiation: your PSA meets the ASTRO-Phoenix “nadir + rise” rule.
- You can take part in the scan safely: you can lie still during the PET scan and you do not have major salivary gland disease (and not Paget’s disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.
This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.
This trial looks at how well a special PET scan (called PSMA PET) can find prostate cancer that has come back after treatment. It uses a radioactive tracer to spot cancer cells. Your doctor may already have ordered this scan as part of your regular care.
This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
This study uses a special scan called PET/MR with a prostate-focused tracer to help doctors choose the best next treatment for prostate cancer. It may be most helpful if you are planning major treatment or if your cancer has come back after prior treatment.
Hear when a new Biochemical Recurrence of Malignant Neoplasm of Prostate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.